THAM-E Drug Patent Profile
✉ Email this page to a colleague
When do Tham-e patents expire, and when can generic versions of Tham-e launch?
Tham-e is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in THAM-E is potassium chloride; sodium chloride; tromethamine. There are two hundred and forty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the potassium chloride; sodium chloride; tromethamine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THAM-E?
- What are the global sales for THAM-E?
- What is Average Wholesale Price for THAM-E?
Summary for THAM-E
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 341 |
| Patent Applications: | 1,791 |
| DailyMed Link: | THAM-E at DailyMed |
US Patents and Regulatory Information for THAM-E
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | THAM-E | potassium chloride; sodium chloride; tromethamine | INJECTABLE;INJECTION | 013025-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
